Juniper Investment Company, LLC
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 14, 2025), Juniper Investment Company, LLC reported 9 stock positions worth $261.4 million. Its top holding was Artivion (AORT) at 21.6% of the portfolio, followed by Lincoln Educational Services (LINC, 21.2%) and Bioventus Class A (BVS, 17.8%). Compared with Q2 2025, it sold out of 2, added to 1 and reduced 1. The biggest buy was Orthofix Medical (OFIX, shares +15%) and the biggest sale Artivion (AORT, shares −36%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001794034
- Portfolio Value
- $261.4M (Q3 2025)
- SEC Filing
- 0001214659-25-016625 ↗ filed Nov 14, 2025
Holdings Value
Holdings 9 stocks · $261.4M
| AORT Artivion Inc. | 21.60% | 1,333,692 | $56.5M | Reduce -36.3% |
| LINC Lincoln Educational Services | 21.24% | 2,363,311 | $55.5M | No change |
| BVS Bioventus Inc. Class A | 17.76% | 6,939,357 | $46.4M | No change |
| OFIX Orthofix Medical Inc. | 15.94% | 2,847,055 | $41.7M | Add +15.3% |
| ALNT Allient Inc. | 14.88% | 869,149 | $38.9M | No change |
| TWIN Twin Disc Inc. | 5.47% | 1,024,954 | $14.3M | No change |
| ALOT Astronova Inc. | 2.10% | 535,203 | $5.5M | No change |
| LYTS Lsi Industries Inc. | 0.99% | 109,811 | $2.6M | No change |
| POCI Precision Optics Corp. Inc. | 0.03% | 15,502 | $67K | No change |
Portfolio Sells Q2 2025 → Q3 2025
Portfolio Buys Q2 2025 → Q3 2025
| OFIX Orthofix Medical Inc. | Add +15.3% | 15.94% | +4.59 |
Options Activity Q2 2025 → Q3 2025
| BA The Boeing Co. | call | Sold out | 3,000 | $629Kbefore exit |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 10 | $377.5M | LINC, ALNT, BVS, AORT, OFIX |
| Q1 2026 | 8 | $313.1M | LINC, BVS, ALNT, OFIX, AORT |
| Q4 2025 | 8 | $290.9M | LINC, AORT, OFIX, BVS, ALNT |
| Q3 2025 | 9 | $261.4M | AORT, LINC, BVS, OFIX, ALNT |
| Q2 2025 | 11 | $242.6M | AORT, LINC, BVS, ALNT, OFIX |
| Q1 2025 | 11 | $221.9M | BVS, AORT, LINC, OFIX, ALNT |
| Q4 2024 | 11 | $253.5M | BVS, AORT, LINC, OFIX, ALNT |
| Q3 2024 | 12 | $239.5M | BVS, AORT, LINC, ALNT, OFIX |
| Q2 2024 | 12 | $208.6M | AORT, LINC, BVS, VSEC, ALNT |
| Q1 2024 | 10 | $201.0M | AORT, BVS, LINC, VSEC, ALNT |